GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
201 hedge funds and large institutions have $2.29B invested in Genomic Health, Inc. in 2018 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 62 increasing their positions, 52 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more call options, than puts
Call options by funds: $5.13M | Put options by funds: $4.4M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
201
Holding in Top 10
4
Calls
$5.13M
Puts
$4.4M
Top Buyers
| 1 | +$30M | |
| 2 | +$26.8M | |
| 3 | +$26.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.7M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$19.6M |
Top Sellers
| 1 | -$124M | |
| 2 | -$36.7M | |
| 3 | -$23.2M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$6.77M |
| 5 |
D.E. Shaw & Co
New York
|
-$5.87M |